Patents Assigned to XIANGYA HOSPITAL CENTRAL SOUTH UNIVERSITY
  • Publication number: 20200111224
    Abstract: A gyroscope-based system and method is disclosed. Image information data is collected; a mechanical arm working environment image is modeled; a heat source supply apparatus and a gyroscope are provided at the mechanical arm proximal end; the position of the proximal end is accurately measured by accurately tracking the heat source at the proximal end; the relative position of the mechanical arm distal end is accurately calculated by using high-precision angle information measured by the high-precision gyroscope in combination with a number-theoretic formula. The disclosure provides separately determining the position of the distal end, or for assisting other algorithms or apparatuses that track the position of the mechanical arm distal end in error correction and calibration of the position of the mechanical arm distal end. The position of the mechanical arm distal end can be continuously and dynamically tracked in real time, and virtualized in the corresponding image system.
    Type: Application
    Filed: January 2, 2019
    Publication date: April 9, 2020
    Applicants: CENTRAL SOUTH UNIVERSITY, THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
    Inventors: Li Xiong, Siyuan Tang, Jingjing Jiao, Jiangjie Zhang
  • Publication number: 20200000769
    Abstract: The present invention relates to the use of N-(2-aminoethyl)-N-(4-benzyloxy)-3-methoxybenzyl)thiophene-2-formamide hydrochloride for treating liver cancer. The N-(2-aminoethyl)-N-(4-benzyloxy)-3-methoxybenzyl)thiophene-2-formamide hydrochloride of the present invention can effectively inhibit the growth of liver cancer cells and has a therapeutic effect on liver cancer.
    Type: Application
    Filed: March 8, 2017
    Publication date: January 2, 2020
    Applicant: The Second Xiangya Hospital, Central South University
    Inventor: Xundi Xu
  • Publication number: 20190331698
    Abstract: The present invention relates to a molecular marker, a kit and an application for early diagnosis and prediction of sepsis acute kidney injury (AKI). TCONS_00024536 is highly expressed in the blood of sepsis AKI patients. By detecting the expression level of TCONS_00024536 in the blood of patients, whether the patients suffer from sepsis AKI or the probability of suffering from sepsis AKI can be judged. The present invention is of great significance for specific and sensitive early diagnosis and prediction of sepsis AKI.
    Type: Application
    Filed: May 7, 2019
    Publication date: October 31, 2019
    Applicant: THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
    Inventors: Dongshan ZHANG, Siyuan QU, Huiling LI, Pan ZHANG